Costantino Pitzalis Selected Research

Costantino Pitzalis Research Topics

Disease

71	Rheumatoid Arthritis 04/2024 - 11/2002
44	Inflammation (Inflammations) 04/2024 - 11/2002
30	Arthritis (Polyarthritis) 11/2023 - 04/2005
13	Synovitis 11/2023 - 03/2015
12	Osteoarthritis 11/2023 - 01/2006
8	Necrosis 01/2021 - 09/2014
8	Neoplasms (Cancer) 01/2021 - 11/2007
6	Disease Progression 11/2023 - 09/2011
6	Autoimmune Diseases (Autoimmune Disease) 03/2023 - 04/2006
5	Psoriatic Arthritis 01/2021 - 04/2004
5	Tertiary Lymphoid Structures 12/2019 - 09/2010
4	Pain (Aches) 04/2024 - 01/2016
4	Sialadenitis 01/2020 - 01/2004
3	Rheumatic Diseases (Rheumatism) 11/2023 - 01/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2016
3	Peritonitis 01/2022 - 01/2013
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 02/2010
3	Experimental Arthritis 12/2019 - 12/2010
3	Fatigue 01/2017 - 01/2014
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2016 - 01/2009
3	Lymphoma (Lymphomas) 08/2012 - 01/2008
3	Ankylosing Spondylitis 11/2010 - 04/2009
2	Infections 01/2020 - 09/2015
2	Arthralgia (Joint Pain) 01/2018 - 01/2017
2	Multiple Sclerosis 01/2017 - 04/2006
2	Sjogren's Syndrome (Sjogren Syndrome) 01/2017 - 08/2012
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2008 - 10/2007
1	Joint Diseases (Joint Disease) 11/2023
1	Chronic Disease (Chronic Diseases) 03/2023
1	Leiomyoma (Uterine Fibroids) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2021
1	Proteinuria 01/2021
1	Nephritis 01/2021
1	Lupus Nephritis 01/2021

Drug/Important Bio-Agent (IBA)

18	CytokinesIBA 01/2023 - 11/2002
15	RNA (Ribonucleic Acid)IBA 11/2023 - 09/2013
12	AutoantibodiesIBA 01/2023 - 11/2008
11	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2008
11	AntigensIBA 03/2023 - 07/2006
10	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2009
10	LigandsIBA 10/2023 - 04/2008
9	Antirheumatic Agents (DMARD)IBA 11/2023 - 07/2016
7	Rituximab (Mabthera)FDA Link 11/2023 - 01/2008
7	AntibodiesIBA 12/2018 - 04/2011
7	Peptides (Polypeptides)IBA 10/2016 - 11/2010
6	ChemokinesIBA 01/2018 - 04/2008
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2008
5	Interleukin-6 (Interleukin 6)IBA 03/2024 - 12/2010
4	InterferonsIBA 01/2023 - 01/2016
4	Interleukin-1 (Interleukin 1)IBA 11/2021 - 04/2011
4	LipidsIBA 10/2020 - 01/2013
4	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 09/2014
3	tocilizumab (atlizumab)FDA Link 11/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 11/2009
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 04/2009
3	Interleukin-27 (Interleukin 27)IBA 01/2020 - 10/2015
3	Lactic Acid (Lactate)FDA LinkGeneric 12/2019 - 07/2015
3	Monoclonal AntibodiesIBA 01/2018 - 09/2014
2	Tyrosine (L-Tyrosine)FDA Link 03/2024 - 01/2019
2	c-Mer Tyrosine KinaseIBA 03/2024 - 01/2021
2	SynteninsIBA 12/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 09/2013
2	Methotrexate (Mexate)FDA LinkGeneric 11/2022 - 01/2018
2	Small Cytoplasmic RNAIBA 01/2022 - 01/2019
2	ZymosanIBA 01/2022 - 01/2013
2	EnzymesIBA 11/2021 - 01/2009
2	Adalimumab (Humira)FDA Link 01/2021 - 10/2015
2	Therapeutic UsesIBA 01/2021 - 04/2006
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 04/2009
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2018
2	GlucocorticoidsIBA 01/2020 - 11/2012
2	serum P-component (CIt)IBA 01/2018 - 10/2016
2	InterleukinsIBA 08/2017 - 07/2003
2	AutoantigensIBA 10/2016 - 09/2013
2	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2016 - 01/2016
2	Interleukin-18 (Interleukin 18)IBA 04/2011 - 01/2004
2	Cytidine DeaminaseIBA 01/2009 - 10/2007
1	SolventsIBA 04/2024
1	Phosphotransferases (Kinase)IBA 03/2024
1	Syndecan-1 (Syndecan 1)IBA 12/2023
1	Etanercept (Enbrel)FDA Link 11/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2023
1	Chemokine CXCL6IBA 11/2023
1	Antigen Receptors (Antigen Receptor)IBA 03/2023
1	AutacoidsIBA 05/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Becaplermin (PDGF-BB)FDA Link 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	KN 93IBA 11/2021
1	CalciumIBA 11/2021
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 11/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 11/2021
1	CreatinineIBA 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021

Therapy/Procedure

35	Therapeutics 11/2023 - 04/2004
7	Biological Therapy 11/2023 - 12/2010
3	Arthroplasty 04/2024 - 01/2006
3	Aftercare (After-Treatment) 12/2022 - 01/2020
2	Intra-Articular Injections 01/2017 - 11/2015
1	Precision Medicine 02/2021